Ethics

ISO 37001 is an international standard for anti-bribery management systems established in October 2016 by the International Organization for Standardization (ISO), with participation from 162 countries worldwide. It aims to systematically control and manage the risk of bribery within organizations.
To obtain ISO 37001 certification, Daewoong Pharmaceutical applied and analyzed international standards related to fair trade laws, the Improper Solicitation and Graft Act, and compliance practices within its business operations. The company carried out enterprise-wide initiatives including CP (Compliance Program) training for employees, risk assessments and evaluations of bribery-related threats, goal management, and internal audits. As a result of these comprehensive efforts, Daewoong was awarded the ISO 37001 international certification in December 2018.
Since then, Daewoong has consistently demonstrated the effectiveness of its anti-bribery management system, successfully passing annual surveillance audits as well as the second recertification audit in December 2024, thereby continuing its commitment to ethical and transparent business practices.